Alzheimer’s disease medicine
-
Long March of Sodium Oligomannate – Innovative Alzheimer’s disease Drug from China
Sodium Oligomannate (GV-971, also known as Sodium Oligo-mannurarate), the innovative drug for Alzheimer’s disease was conditionally approved by China NPMA 2019. International multi centered Phase III clinical trial is started in the United Stated following the most recent report.
